Bharat Parenterals share news and announcements
NSE: BPLPHARMABSE: 541096Pharmaceuticals & BiotechnologySmall Cap
Last close ₹1,690.00down ₹86.00 (4.84%)BSE ₹1,662.75
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,776.00.
52-week range of BSE trades to 23 Oct 2026
₹880.25Low, 30 Mar 2026₹2,274.10High, 28 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,165 Cr1,597th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Owners' profit not stated
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 18 May 2026
- 3.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.06%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 5 Aug 2026
- −5.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 18 May 2026
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,08940.3% delivered
Bharat Parenterals board meetings
100 filed, newest first. Page 1 of 2.
Sep 2026
24 Sep · Board meeting
Meeting on 29 Sep 2026: preferential issue of shares
Jul 2026
28 Jul · Board meeting
Meeting on 5 Aug 2026: annual general meeting and quarterly results
May 2026
11 May · Board meeting
Meeting on 18 May 2026: audited results, final dividend and quarterly results
Jan 2026
22 Jan · Board meeting
Meeting on 30 Jan 2026: quarterly results
Nov 2025
6 Nov · Board meeting
Meeting on 12 Nov 2025: quarterly results
Jul 2025
22 Jul · Board meeting
Meeting on 28 Jul 2025: annual general meeting and quarterly results
May 2025
12 May · Board meeting
5 May · Board meeting
Meeting on 12 May 2025: final dividend and audited results
Jan 2025
23 Jan · Board meeting
Meeting on 3 Feb 2025: quarterly results
Oct 2024
21 Oct · Board meeting
Meeting on 29 Oct 2024: quarterly results
Jul 2024
31 Jul · Board meeting
Meeting on 8 Aug 2024: quarterly results
Jun 2024
10 Jun · Board meeting
6 Jun · Board meeting
Meeting on 10 Jun 2024: annual general meeting and preferential issue of shares
May 2024
27 May · Board meeting
Meeting on 5 Jun 2024: annual general meeting10 May · Board meeting
Meeting on 22 May 2024: audited results and quarterly results
Apr 2024
29 Apr · Board meeting
25 Apr · Board meeting
Meeting on 29 Apr 2024: preferential issue of shares
Jan 2024
31 Jan · Board meeting
Meeting on 13 Feb 2024: quarterly results
Nov 2023
1 Nov · Board meeting
Meeting on 9 Nov 2023: quarterly results
Aug 2023
1 Aug · Board meeting
Meeting on 9 Aug 2023: quarterly results
May 2023
8 May · Board meeting
Meeting on 20 May 2023: final dividend, quarterly results and audited results
Feb 2023
9 Feb · Board meeting
Meeting on 13 Feb 2023: quarterly results
Nov 2022